410 filings
Page 8 of 21
5
iu44 7g29u
14 Feb 23
Cerevel Therapeutics / Gabrielle Sulzberger ownership change
5:47pm
SC 13G/A
w33nukhzfecbghsx2e1
9 Feb 23
Cerevel Therapeutics / FMR ownership change
9:59am
4
7dxpqva4uc cx1fgf2w
8 Feb 23
Cerevel Therapeutics / John Renger ownership change
8:34pm
4
wtowin
8 Feb 23
Cerevel Therapeutics / Kathleen Tregoning ownership change
8:30pm
4
8x8dgogv1 nt6a
8 Feb 23
Cerevel Therapeutics / Abraham Ceesay ownership change
8:29pm
4
2xqyxk u5d9nykxlwwy2
8 Feb 23
Cerevel Therapeutics / Scott Akamine ownership change
8:29pm
4
mymh5rorq8lb6lnpz1kx
8 Feb 23
Cerevel Therapeutics / N ANTHONY COLES ownership change
8:27pm
4
sot0arvzm5igdum0v
8 Feb 23
Cerevel Therapeutics / Mark Bodenrader ownership change
8:26pm
4
u9of rygbwi
8 Feb 23
Cerevel Therapeutics / Ramiro Sanchez ownership change
8:25pm
4
ugx2cxniajv1cp fj7r
8 Feb 23
Cerevel Therapeutics / Kenneth DiPietro ownership change
8:25pm
8-K
izajj3l7 kduzvxkp
9 Jan 23
Cerevel Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference and Provide Pipeline Update
8:01am
4
hr2nu4rlvflmy9x
6 Jan 23
Cerevel Therapeutics / N ANTHONY COLES ownership change
5:04pm
8-K
nb2d1m4fqql5d3y4jd
19 Dec 22
Cerevel Therapeutics Announces Positive Results in Emraclidine Ambulatory Blood Pressure Monitoring Trial
8:00am
4
6e7r56l6 3fwnp
13 Dec 22
Cerevel Therapeutics / N ANTHONY COLES ownership change
4:44pm
EFFECT
xj1x6oir53lbkfw
21 Nov 22
Notice of effectiveness
12:15am
CORRESP
w9l04
16 Nov 22
Correspondence with SEC
12:00am
UPLOAD
hb77hacbmt si
10 Nov 22
Letter from SEC
12:00am
8-K
s8tc0sgux2y
8 Nov 22
Cerevel Therapeutics Reports Third Quarter 2022 Financial Results and Business Updates
6:36am